tiger9844

Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone

doug, Endo (Durect) is working on one however they are working on the extended release not the immediate release that Acura has put together. There are multiple competitors in this sector, but unlike most extended release versions Acura targets the immediate release market. In addition Acura's patented platform has several trailing drugs in the works and can also be applied to over the counter medicines. Oh, and the whole thing is global, not just in the U.S.

Also, this article was taken from this bogus company's website and until they were called out last night they only had one link on the entire site which was that to this attempt to bash Acura. back is right and someone desperately wants to spread false information about Acura.